Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs dexmedetomidine for delirium and hemodynamics in postoperative mechanically ventilated SICU patients
ChiCTR2500109184Phase 4Not yet recruiting
- Sponsor
- Guilin People's Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in delirium, Cardiovascular collapse, postoperative pain and 1 more (2 arms), sponsored by Guilin People's Hospital. Primary endpoint: Delirium incidence. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
deliriumCardiovascular collapsepostoperative painSedation requirement
Beyond the preview
Go deeper on ChiCTR2500109184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109184.